- Home
- AWX vs MYNZ Comparison
AWX vs MYNZ Comparison
Compare AWX & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AWX | MYNZ |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 8.8M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AWX | MYNZ |
|---|---|---|
| Price | $2.61 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 8.7K | ★ 188.9K |
| Earning Date | 11-07-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $79,712,000.00 | $659,935.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | $57.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.10 | $0.92 |
| 52 Week High | $5.43 | $8.20 |
Technical Indicators
Market Signals| Indicator | AWX | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 54.02 |
| Support Level | $2.55 | $1.00 |
| Resistance Level | $2.80 | $1.15 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 23.97 | 76.27 |
Price Performance
Historical ComparisonAbout AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.